Response to Highly Active Antiretroviral Therapy According to Duration of HIV Infection

This publication has 27 references indexed in Scilit:

• Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies
  AIDS, 1999
• Changing patterns of mortality across Europe in patients infected with HIV-1
  The Lancet, 1998
• Simultaneous vs Sequential Initiation of Therapy With Indinavir, Zidovudine, and Lamivudine for HIV-1 Infection
  JAMA, 1998
• Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy
  Nature Medicine, 1998
• Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
  BMJ, 1997
• Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
  New England Journal of Medicine, 1997
• A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
  New England Journal of Medicine, 1997
• HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
  Nature Medicine, 1997
• The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia
  Proceedings of the National Academy of Sciences, 1997
• Genotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection
  Science, 1993